Evaluate the clinical real world data of safety, tolerability and efficacy of Personalized Rasayana therapy on Quality of life (QoL) of elderly patients with gastrointestinal tumors who are refractory or ineligible to conventional anti-malignant therapies - QoL in Gastrointestinal tumours

Rasayu Cancer Clinic Pune0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1 Histopathologically diagnosed Patients with gastrointestinal cancer which includes stomach colorectal pancreas esophagus Liver cancers etc
•2 Male and Female patient above the age of 60 years
•3 Patients who are ineligible to receive conventional anticancer therapy
•4 Patients for whom no conventional anticancer therapy exist
•5 Those that are willingly refusing conventional anticancer therapy with the reason known
•6 Patients having resistance to conventional therapies like chemotherapy,immunotherapy etc
•7.Patients who are willing to take exclusively Rasayana therapy

•1 Patients taking any other conventional or alternative treatment which is known to significantly impact Patients Quality of life
•2 Patients receiving any conventional anticancer therapy
•3 Patients with any psychiatric disturbance major depression psychosis which will impair Patients ability to respond the questions in QoL questionnaire
•4 Patients with cerebral mets
•5 Patients with taking analgesics
•6 Patients with expected survival of less than 3 months

发起方

Rasayu Cancer Clinic Pune